EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier

 

2021
  • Cuzin L, Allavena C, Cotte L, Delpierre C, Huleux T, Palich R, Delobel P, Raffi F, Cabié A; Dat’AIDS Study Group. No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study. J Antimicrob Chemother. 2021 Mar 10:dkab061. doi: 10.1093/jac/dkab061. Epub ahead of print.
2020
  • Couffignal C, Kolta S, Flamant M, Cazanave C, Haymann JP, Mentré F, Duval X, Leport C, Raffi F, APROCO-COPILOTE ANRS CO8 Study Group (Cuzin L collaborator). Nevirapine Use Is Associated with Higher Bone Mineral Density in HIV-1 Positive Subjects on Long-Term Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020;36(5):399‐405. doi:10.1089/AID.2019.0229.
     
  • Hentzien M, Cuzin L, Raffi F, Jacomet C, Reynes J, Rey D, Ravaux I, Cheret A, Viguier M, Bani-Sadr F , Dat’AIDS study group. Factors associated with psoriasis in a French Nationwide HIV cohort: the independent role of HLA-B*57:01. AIDS. 2020;34(7):1057‐1063.doi:10.1097/QAD.0000000000002519.
     
  • Le Guillou A, Pugliese P, Raffi F, Cabie A, Cuzin L, Katlama C, Allavena C, Drame M, Cotte L, Bani-Sadr F; Dat’AIDS Study Group. Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort. Clin Infect Dis. 2020 Jul 11;71(2):293-300. doi: 10.1093/cid/ciz800.
     
  • Pircher M, Pitono E, Pierre-François S, Molcard S, Brunier-Agot L, Fagour L, Najioullah F, Cesaire R, Abel S, Cuzin L, Cabié A. The effects of chikungunya virus infection on people living with HIV during the 2014 Martinique outbreak. PLoS One. 2020;15(6):e0234267.  doi:10.1371/journal.pone.0234267.
     
  • Poizot-Martin I, Obry-Roguet V, Duvivier C, Lions C, Huleux T, Jacomet C, Ferry T, Cheret A, Allavena C , Bani-Sadr F, Palich R, Cabié A , Fresard A, Pugliese P, Delobel  P, Lamaury I, Hustache-Mathieu L, Brégigeon S, Makinson  A , Rey D, Dat'AIDS study group (Cuzin L collaborator). Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015. J Eur Acad Dermatol Venereol. 2020;34(5):1065‐1073. doi:10.1111/jdv.16204.
     
  • Ursenbach A, Max V, Maurel M, Bani-Sadr F, Gagneux-Brunon A, Garraffo R, Ravaux I, Robineau O, Makinson A, Rey D; Dat’AIDS Study Group (Cuzin L collaborator). Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study. J Antimicrob Chemother. 2020 Nov 1;75(11):3344-3348. doi: 10.1093/jac/dkaa330.
2019
  • Cuzin L, Cotte L, Delpierre C, Allavena C, Valantin MA, Rey D, Delobel P, Pugliese P, Raffi F, Cabié A; Dat’AIDS Study group. Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohort. PLoS One. 2019 Sep 6;14(9):e0222067. doi: 10.1371/journal.pone.0222067.
     
  • Cuzin L, Pugliese P, Katlama C, Bani-Sadr F, Ferry T, Rey D, Lourenco J, Bregigeon S, Allavena C, Reynes J, Cabié A; Dat’AIDS Study Group. Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort. J Antimicrob Chemother. 2019 Mar 1;74(3):754-760. doi: 10.1093/jac/dky497.
     
  • Durier C , Desaint C , Lelièvre JD , Silbermann B, Pialoux G, Cuzin L , Bonnet B, Poizot-Martin I, Bouakane A, Paul C, Grabar S , Spire B , Meyer L , Launay O, ANRS/VRI COHVAC Study Group Long-term Safety and Vaccine-Induced Seropositivity in Healthy Volunteers From HIV Vaccine Trials. AIDS. 2019. 33 (13), 2061-2071. doi: 10.1097/QAD.0000000000002310.
     
  • Hentzien M, Dramé M, Delpierre C, Allavena C, Cabié A, Cuzin L, Rey D, Pugliese P, Hédelin G, Bani-Sadr F; Dat’AIDS Study Group. HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort. BMJ Open. 2019 Jan 25;9(1):e024841. doi: 10.1136/bmjopen-2018-024841.
     
  • Lions C, Cabras O, Cotte L, Huleux T, Gagneux-Brugnon A, Makinson A, Cabié A, Bonnet B, Duvivier C, Hocqueloux L, Cua E, Cheret A, Hustache-Mathieu L, Obry-Roguet V, Jacomet C, Poizot-Martin I; DAT’AIDS STUDY GROUP. (Cuzin L. collaborator) Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort. BMC Infect Dis. 2019 Mar 25;19(1):278. doi: 10.1186/s12879-019-3915-5.
     
  • Pugliese P, Joly V, Valantin MA, Cotte L, Huleux T, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Cuzin L; Dat’AIDS group. Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France. Med Mal Infect. 2019 Jun;49(4):264-269. doi: 10.1016/j.medmal.2018.10.005.
     
  • Sagaon-Teyssier L, Vilotitch A, Mora M, Maradan G, Guagliardo V, Suzan-Monti M, Dray-Spira R, Spire B; VESPA2 study group.  (Cuzin L. collaborator) A generalized additive model to disentangle age and diagnosis-specific cohort effects in psychological and behavioral outcomes in people living with HIV: the French cross-sectional ANRS-VESPA2 survey. BMC Public Health. 2019 May 17;19(1):590. doi: 10.1186/s12889-019-6905-z.    
     
Mise à jour novembre 2020